A microstructural retinal analysis of membrano-proliferative glomerulonephritis type II.
作者信息
Gerth C, Zawadzki R J, Licht C, Werner J S, Héon E
机构信息
Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children and The University of Toronto, Canada.
出版信息
Br J Ophthalmol. 2008 Aug;92(8):1150-1. doi: 10.1136/bjo.2007.122549.
Abstract
摘要
相似文献
1
A microstructural retinal analysis of membrano-proliferative glomerulonephritis type II.
Br J Ophthalmol. 2008 Aug;92(8):1150-1. doi: 10.1136/bjo.2007.122549.
2
Functional and morphological macular abnormalities in membranoproliferative glomerulonephritis type II.
Br J Ophthalmol. 2010 Aug;94(8):1112-4. doi: 10.1136/bjo.2009.159475.
3
Retinal manifestations in patients with complement-mediated membranoproliferative glomerulonephritis.
Arch Soc Esp Oftalmol (Engl Ed). 2019 Feb;94(2):95-99. doi: 10.1016/j.oftal.2018.06.013. Epub 2018 Aug 2.
4
Bilateral macular sub-retinal fluid and retinal pigment epithelial detachment associated with type 2 membrano-proliferative glomerulonephritis.
Clin Exp Optom. 2008 Sep;91(5):476-9. doi: 10.1111/j.1444-0938.2008.00268.x. Epub 2008 Apr 18.
5
Progressive Retinochoroidal Atrophy in Dense Deposit Disease.
Ophthalmol Retina. 2021 Jul;5(7):663. doi: 10.1016/j.oret.2021.04.008.
6
Optical coherence tomography of fundus abnormalities associated with type II membranoproliferative glomerulonephritis.
Retina. 2003 Apr;23(2):261-2. doi: 10.1097/00006982-200304000-00026.
7
Subretinal fluid associated with membranoproliferative glomerulonephritis type 2.
Arch Ophthalmol. 1997 Jul;115(7):927-8. doi: 10.1001/archopht.1997.01100160097022.
8
Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease").
Am J Kidney Dis. 2003 Aug;42(2):E2-5. doi: 10.1016/s0272-6386(03)00665-6.
9
Specific eye fundus lesions in type II membranoproliferative glomerulonephritis.
Pediatr Nephrol. 1991 Mar;5(2):189-92. doi: 10.1007/BF01095950.
10
[Ocular impairment during type II membranoproliferative glomerulonephritis].
J Fr Ophtalmol. 2002 Nov;25(9):949-54.
引用本文的文献
1
The Retinal Complications of C3 Dense Deposit Disease: A Scoping Review.
Vision (Basel). 2025 Aug 1;9(3):64. doi: 10.3390/vision9030064.
本文引用的文献
1
Visualization of lipofuscin accumulation in Stargardt macular dystrophy by high-resolution Fourier-domain optical coherence tomography.
Arch Ophthalmol. 2007 Apr;125(4):575. doi: 10.1001/archopht.125.4.575.
2
MPGN II--genetically determined by defective complement regulation?
Pediatr Nephrol. 2007 Jan;22(1):2-9. doi: 10.1007/s00467-006-0299-8. Epub 2006 Sep 23.
3
Clinical application of rapid serial fourier-domain optical coherence tomography for macular imaging.
Ophthalmology. 2006 Aug;113(8):1425-31. doi: 10.1016/j.ophtha.2006.03.020. Epub 2006 Jun 12.
4
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32. doi: 10.1073/pnas.0501536102. Epub 2005 May 3.
5
Standard for clinical electroretinography (2004 update).
Doc Ophthalmol. 2004 Mar;108(2):107-14. doi: 10.1023/b:doop.0000036793.44912.45.
6
In vivo human retinal imaging by Fourier domain optical coherence tomography.
J Biomed Opt. 2002 Jul;7(3):457-63. doi: 10.1117/1.1482379.
7
Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report.
Br J Ophthalmol. 1989 Apr;73(4):297-302. doi: 10.1136/bjo.73.4.297.
8
Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings.
Br J Ophthalmol. 1989 Nov;73(11):900-6. doi: 10.1136/bjo.73.11.900.
9
Specific eye fundus lesions in type II membranoproliferative glomerulonephritis.
Pediatr Nephrol. 1991 Mar;5(2):189-92. doi: 10.1007/BF01095950.
Zotero 插件